VXBIOSCIENCES, INC

Address: 1431 CENTER ST APT 201 OAKLAND, CA 94607-2065
County: ALAMEDA
Country: UNITED STATES
UEI: WY7EALRMMHL7

Issue Date FY

Legal Entity Zip Code

Issue Date FY: 2025 ( Subtotal = -$1,329,156 )

2025

2023

VXBIOSCIENCES, INC

1431 CENTER ST APT 201

OAKLAND

94607-2065

ALAMEDA

USA

R42AI174554

Development of a first-in-class antiviral to address CMV drug resistance in immunocompromised patients

000

NIH

5/1/2025

2025

2021

VXBIOSCIENCES, INC

1431 CENTER ST APT 201

OAKLAND

94607-2065

ALAMEDA

USA

R01AI169443

Autonomously deploying, co-evolving SARS-CoV-2 antiviral: a new paradigm for pandemic prevention

000

NIH

2/10/2025

-$1,329,156

Issue Date FY: 2024 ( Subtotal = $0 )

2024

2023

VXBIOSCIENCES, INC.

1431 CENTER ST APT 201

OAKLAND

94607-2065

ALAMEDA

USA

R01AI169443

Autonomously deploying, co-evolving SARS-CoV-2 antiviral: a new paradigm for pandemic prevention

001

NIH

1/22/2024

2024

2021

VXBIOSCIENCES, INC.

1431 CENTER ST APT 201

OAKLAND

94607-2065

ALAMEDA

USA

R01AI169443

Autonomously deploying, co-evolving SARS-CoV-2 antiviral: a new paradigm for pandemic prevention

000

NIH

1/22/2024

Issue Date FY: 2023 ( Subtotal = $2,297,089 )

2023

VXBIOSCIENCES, INC.

1431 CENTER ST APT 201

OAKLAND

94607-2065

ALAMEDA

USA

R42AI174554

Development of a first-in-class antiviral to address CMV drug resistance in immunocompromised patients

000

NIH

9/12/2023

$300,000

2023

VXBIOSCIENCES, INC.

1431 CENTER ST APT 201

OAKLAND

94607-2065

ALAMEDA

USA

R01AI169443

Autonomously deploying, co-evolving SARS-CoV-2 antiviral: a new paradigm for pandemic prevention

001

NIH

7/12/2023

$1,997,089

2023

2021

VXBIOSCIENCES, INC.

1431 CENTER ST APT 201

OAKLAND

94607-2065

ALAMEDA

USA

R01AI169443

Autonomously deploying, co-evolving SARS-CoV-2 antiviral: a new paradigm for pandemic prevention

000

NIH

7/11/2023

Issue Date FY: 2021 ( Subtotal = $2,820,494 )

2021

VXBIOSCIENCES, INC.

945 SUNNYHILLS RD

OAKLAND

94610-2414

ALAMEDA

USA

R01AI169443

Autonomously deploying, co-evolving SARS-CoV-2 antiviral: a new paradigm for pandemic prevention

000

NIH

9/24/2021

$2,820,494

All Categories

About

Search

Reports

Data Submission

Recipient Information

VXBIOSCIENCES, INC

Address: 1431 CENTER ST APT 201 OAKLAND, CA 94607-2065

County: ALAMEDA

Country: UNITED STATES

UEI: WY7EALRMMHL7

Issue Date FY Summary

Issue Date FY by OPDIV

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer